AuRx is currently seeking accredited investors!

Please contact Dr. Gary Calton at gcalton@aurx.com for more information.

This investment will allow AuRx Inc. to build and operate a production facility. AuRx Plans to run a Phase 3 clinical trial for treating the HSV-1 and HSV-2 virus.

AuRx is also setting up a Phase 1-2 clinical trial for treatment of Breast Cancer with an emphasis on destruction of Cancer Stem Cells.